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Lyme disease, caused by the bacterium Borrelia burgdorferi, is the most widespread tick-borne infection in the
northern hemisphere that results in a multistage disorder with concomitant pathology, including arthritis.
During late-stage experimental infection in mice, B. burgdorferi evades the adaptive immune response despite
the presence of borrelia-specific bactericidal antibodies. In this study we asked whether B. burgdorferi could
invade fibroblasts or endothelial cells as a mechanism to model the avoidance from humorally based clearance.
A variation of the gentamicin protection assay, coupled with the detection of borrelial transcripts following
gentamicin treatment, indicated that a portion of B. burgdorferi cells were protected in the short term from
antibiotic killing due to their ability to invade cultured mammalian cells. Long-term coculture of B. burgdorferi
with primary human fibroblasts provided additional support for intracellular protection. Furthermore, de-
creased invasion of B. burgdorferi in murine fibroblasts that do not synthesize the 1 integrin subunit was
observed, indicating that 1-containing integrins are required for optimal borrelial invasion. However, 1-
dependent invasion did not require either the 51 integrin or the borrelial fibronectin-binding protein
BBK32. The internalization of B. burgdorferi was inhibited by cytochalasin D and PP2, suggesting that B.
burgdorferi invasion required the reorganization of actin filaments and Src family kinases (SFK), respectively.
Taken together, these results suggest that B. burgdorferi can invade and retain viability in nonphagocytic cells
in a process that may, in part, help to explain the phenotype observed in untreated experimental infection.
Borrelia burgdorferi sensu lato is the causative agent of Lyme
disease and the most widespread arthropod infection in North
America, Europe, and Asia (3, 60, 80, 81). The disease is
transmitted via Ixodes ticks and presents as a multistage disor-
der that is initially characterized by a flu-like illness and a
painless rash known as erythema migrans (60, 79–81). Subse-
quently the disease can involve cardiac, neurologic, and joint
abnormalities if therapeutic approaches are not sought early in
the infectious process (60, 80, 81). If treated early, patients
generally respond well to antibiotic therapy (80, 81).
During experimental infection in mice, persistence is ob-
served in the absence of antibiotic therapy. These experimen-
tally infected animals have high-titered antibodies that kill
B. burgdorferi in vitro; however, we know strikingly little as to
how these spirochetes evade humoral clearance under these
conditions. One contributing factor may be that B. burgdorferi
invades nonphagocytic mammalian cells in vivo, thereby pro-
viding an immunoprotected niche. Along these lines, several
groups have reported that B. burgdorferi is able to internalize
into different eukaryotic cells, including endothelial cells, fi-
broblasts, neuronal, and neuroglial cells (24, 46, 52, 53). How-
ever, the fate of internalized spirochetes and the mechanisms
employed by B. burgdorferi to trigger internalization, as well as
the intracellular signaling pathways involved in this process,
remain largely unknown.
In the recent past it has become apparent that both Staph-
ylococcus aureus and Streptococcus pyogenes, although more
commonly known as extracellular pathogens, have an intracel-
lular niche that protects them from host and antibiotic-based
clearance (32, 33, 54, 76, 77, 84). The internalization observed
with the Gram-positive pathogens utilizes host fibronectin,
whereby the bacterium engages soluble fibronectin, via fi-
bronectin-binding proteins (FnBPs) in S. aureus and SfbI in S.
pyogenes (32, 33, 35, 54, 76, 77, 84), binds 51 integrins on
eukaryotic cells, and is internalized in a process that involves
focal adhesion and Src family kinases (SFK) (1, 2, 32, 63).
Since B. burgdorferi binds to fibronectin using the tandem
-zipper model in a manner similar to that seen for Staphylo-
coccus and Streptococcus (17, 37, 44, 65, 68, 71, 72), we were
interested in testing whether B. burgdorferi-fibronectin binding
was also associated with borrelial invasion.
In this report we demonstrate that B. burgdorferi is internal-
ized both within immortalized fibroblasts and within primary
fibroblasts and endothelial cells, all at a low multiplicity of
infection, in a process that is not entirely dependent on BBK32
and the fibronectin-binding integrin 51. Despite the muted
involvement of 51 and fibronectin binding in borrelial inter-
nalization, herein we show that other as-yet-unknown 1 inte-
grins are involved in the invasion of B. burgdorferi into host
cells. Furthermore, these studies indicate that the internaliza-
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tion of B. burgdorferi is dependent on both actin reorganization
and SFK activity. The results presented provide the foundation
to further delineate the role of borrelia-based invasion within
the context of B. burgdorferi infection.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All B. burgdorferi strains and various
transformants are listed in Table 1. All cultures were grown in complete Bar-
bour-Stoenner-Kelly II (BSK-II) liquid medium supplemented with 6% normal
rabbit serum, at 32°C, 1% CO2. For B. burgdorferi, the following antibiotic
concentrations were used in the BSK-II medium: 50 g/ml streptomycin, 50
g/ml gentamicin, and 300 g/ml kanamycin.
Escherichia coli strains TOP10 and DH5 (Invitrogen, Carlsbad, CA) were
used for plasmid propagation under the following antibiotic selection: 5 g/ml
gentamicin, 50 g/ml kanamycin, 100 g/ml spectinomycin, and 15 g/ml chlor-
amphenicol. All E. coli strains were grown at 37°C with aeration.
Plasmid construction. All plasmids used and constructed in this study are
listed in Table 1. A constitutively expressed gfp gene (the cycle 3 gfp allele from
plasmid pcDNA3.1/CT-GFP-TOPO; Invitrogen, Carlsbad, CA) (14), under the
control of the B. burgdorferi flaB promoter, was PCR amplified from plasmid
pBSV(flaBp-gfp) (kindly provided by James Carroll) using the following oligo-
nucleotide primers (5 to 3): proFlaB F, TGT CTG TCG CCT GTG GCT TCC;
and GFP reverse, CTG CTA TTG TCT TCC CAA TCC TCC. The resulting
1,360-bp band was cloned into the entry vector pCR8/GW/TOPO (Invitrogen)
and was designated pJW101. The pCR8/GW/TOPO vector contains attL1 and
attL2 sites for recombination-based transfer of the constitutively expressed cycle
3 gfp allele into the destination vector pBBE22gate (87). To facilitate the di-
rected recombination event, an LR clonase-dependent reaction was performed
with pJW101 and pBBE22gate as previously described (87). The resulting plas-
mid containing the constitutively expressed cycle 3 gfp allele in pBBE22gate was
designated pEW159.
To generate a shuttle vector containing the gfp mut1 allele, pBBE22 (gener-
ously provided by Steve Norris) (67) was digested with KpnI, and a 2.0-kb
fragment containing bbe22 and bbe23 was ligated into KpnI-digested pTM61
(generously provided by Tara Moriarty and George Chaconas) (59). The result-
ing plasmid was designated pJW201.
To track B. burgdorferi genomic copies and transcripts, borrelial recA was PCR
amplified with the following oligonucleotide primers: recA-F, 5-ACG CAA
ATT TTC CAT ATT ACT CAG ATT-3; and recA-R, 5-ACG CAA TTT AAG
AAT GTC AAA GTT AAA-3. The resulting product was cloned into pCR2.1-
TOPO (Invitrogen) to obtain pCR2.1/BbrecA (kindly provided by Dana Shaw).
Mouse fibroblast genomic copies and transcripts were determined as described
previously using murine -actin as a standard (87).
The nucleotide sequence of the aforementioned plasmid constructs isolated
was determined by the Gene Technologies Laboratory, Institute of Developmen-
tal and Molecular Biology, Texas A&M University.
PCR. A PCR was performed to verify plasmid construction and to track
B. burgdorferi plasmid profiles following transformation. All PCRs were per-
formed as previously described using Taq polymerase (Supermix or Supermix
HiFi; Invitrogen, Carlsbad, CA) (39–41, 73, 74). The oligonucleotide primers
used to profile borrelial plasmids have been described previously (47).
Eukaryotic cell culture. The mouse fibroblast cell line L929 and the mouse
fibroblast cell lines GD25 and GD251 (27, 32), as well as the primary normal
human dermal fibroblast (NHDF) cells, were cultivated in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2
mM L-glutamine at 37°C and 5% CO2. GD251 cells were also supplemented
with 10 g/ml puromycin. Human umbilical vein endothelial cells (HUVECs)
TABLE 1. Bacterial strains and plasmid constructs used in this study
Strain or plasmid Commentsa Reference(s)or source
B. burgdorferi strains
MSK5 B. burgdorferi strain B31; contains all known plasmids 47
ML23/pBSV(flaBp-gfp) B. burgdorferi strain B31 lacking only lp25; expresses the cycle 3 gfp allele 14, 47
ML23/pEW159 B. burgdorferi strain B31 lacking only lp25; expresses the cycle 3 gfp allele and
contains bbe22
This study
JS315/pEW159 ML23 derivative carrying bbk32::Strr; expresses the cycle 3 gfp allele and
contains bbe22
This study
ML23/pJW201 B. burgdorferi strain B31 lacking only lp25; expresses the gfp mut1 allele and
contains bbe22
This study
JS315/pJW201 ML23 derivative carrying bbk32::Strr; expresses the gfp mut1 allele and contains
bbe22
This study
JS315/pJW202 ML23 derivative carrying bbk32::Strr; expresses the gfp mut1 allele and contains
bbe22 and bbk32
This study
E. coli strains
TOP10 F mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 araD139
(ara-leu)7697 galU galK rpsL (Strr) endA1 nupG
Invitrogen
DH5 F 80lacZM15 (lacZYA-argF)U169 recA1 endA1 hsdR17 (rK
 mK
	)
supE44 thi-1 gyrA96 relA1 

Invitrogen
Plasmids
pBSV(flaBp-gfp) Borrelial shuttle vector containing constitutively expressed cycle 3 gfp allele; Kanr 14
pBBE22 Borrelial shuttle vector carrying bbe22; Kanr 67
pCR8/GW/TOPO Gateway PCR cloning/entry vector; Spcr Invitrogen
pJW101 pCR8/GW/TOPO containing constitutively expressed cycle 3 gfp allele from
pBSV(flaBp-gfp); Spcr
This study
pBBE22gate pBBE22 modified into a Gateway destination vector containing attR sites; Camr Kanr 87
pEW159 Constitutively expressed cycle 3 gfp allele recombined via Gateway system into
pBBE22gate; Kanr
This study
pTM61 Modified borrelial shuttle vector pTM49 that contains the gfp mut1 allele; Genr 59
pJW201 bbe22 region cloned into pTM61; Genr This study
pCR2.1/BbrecA B. burgdorferi recA cloned into pCR2.1-TOPO; Kanr Ampr This study;
D. Shaw
a Camr, chloramphenicol resistance; Genr, gentamicin resistance; Strr, streptomycin resistance; Ampr, ampicillin resistance; Kanr, kanamycin resistance; Spcr,
spectinomycin resistance.
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were cultured in M199 medium supplemented with 15% FBS, human epidermal
growth factor, hydrocortisone, and bovine brain extract (Clonetics, Cambrex Bio
Science Walkersville, Inc.) at 37°C in 5% CO2 (86). Prior to the addition of
HUVECs to the flask, 1% gelatin (in phosphate-buffered saline [PBS]) was
added to promote adherence.
Bacterial adhesion and internalization assays. Prior to infection, 1 106 L929
murine fibroblasts, HUVECs, and NHDF cells were seeded on glass coverslips
and grown at 37°C in 5% CO2 for 18 h. Prior to B. burgdorferi infection, cells were
washed gently with PBS. Subsequently, 500 l of fresh DMEM or M199 medium
(depending on the eukaryotic cells used) supplemented with 10% FBS was added
to the wells. The eukaryotic cells were then infected with gfp-expressing B.
burgdorferi strains at a multiplicity of infection (MOI) of 1 to 5 for 2 to 18 h.
Following infection, cells were washed three times with prewarmed PBS and then
fixed with 3.7% paraformaldehyde for 30 min at room temperature. In experi-
ments to address the involvement of actin in invasion, 10 nM cytochalasin D
(Sigma/Aldrich, St. Louis, MO) was added to the cell culture medium for 2 h
prior to the addition of B. burgdorferi. To evaluate the requirement of Src family
kinases, 10 M PP2 or 10 nM SU6656 (both from Gibco Corp., Camarillo, CA)
was added to the cell culture medium for 2 h prior to the addition of B.
burgdorferi. In order to test the role of the 51 integrin in borrelial internaliza-
tion, 10 g/ml of the rat monoclonal antibody MAB2575 against mouse 51
integrin (Chemicon, Temecula, CA) was added to the cell culture medium 1 h
prior to infection.
Fluorescence and confocal microscopy. To distinguish intracellular from ex-
tracellular B. burgdorferi cells, fixed cells were washed 5 times with cold PBS and
1% BSA, and the monoclonal antibody BOR-018-48316, specific for B. burgdor-
feri OspA (Capricorn Products, Inc., Portland, ME), was added to the samples.
After a 1-h incubation, cells were washed again with cold PBS and 1% BSA and
incubated with goat anti-mouse secondary IgG antibody conjugated with Alexa
594 (Invitrogen) at room temperature for 1 h. The samples were then washed 5
times with cold PBS containing 1% BSA, and the coverslips mounted on glass
slides containing DAPI (4,6-diamidino-2-phenylindole) and visualized by epi-
fluorescence using a Nikon Eclipse E800 microscope. Extracellular bacteria
fluoresced both red and green (merged subsequently to yellow) when viewed at
the appropriate wavelength (488 nm versus 594 nm for green fluorescent protein
[GFP] and Alexa 594, respectively), whereas intracellular bacteria fluoresced
only green. For confocal microscopy, L929 cells infected with strain ML23/
pEW159 were washed, fixed, and stained as described above. Samples were
visualized using a Zeiss Stallion dual detector imaging system (Carl Zeiss
MicroImaging, Thornwood, NY) with SlideBook software (Intelligent Imaging
Innovations, Inc., Denver, CO). A series of z stacks of images were acquired at
0.5-m intervals with the 63 lens objective and were followed by fluorescence
deconvolution.
Viability assay. To test the viability of B. burgdorferi cultured in cell culture
medium, B. burgdorferi strain B31 derivative MSK5, at 5  107 cells/ml, were
pelleted at 4,000  g for 20 min, washed with PBS, and then cultured in 10 ml
DMEM supplemented with 10% FBS at 37°C in 5% CO2. A 1-ml sample was
removed each day up to 1 week, and the samples were split into 0.5-ml volumes.
One sample was treated at 65°C for 30 min to kill B. burgdorferi to serve as a
positive control for cell death. The parallel sample was assayed using the LIVE/
DEAD BacLight bacterial viability kit (Invitrogen Detection Technologies, Eu-
gene, OR) according to the manufacturer’s protocol. The LIVE/DEAD stain
assay was also used to determine the viability of B. burgdorferi in supplemented
DMEM and treated with either 100 or 200 g/ml gentamicin for 5 h.
Gentamicin protection assay. For invasion studies, 1  106 L929 fibroblasts
were seeded in a 12-well plate overnight. Prior to B. burgdorferi infection, L929
cells were washed gently with PBS, after which 1 ml fresh DMEM with 10% FBS
was added to the wells. The cells were then infected with B. burgdorferi MSK5 at
an MOI of 5 for 18 h. Following this time frame, the supernatant was removed
and placed in new wells, and the remaining L929 cells were washed and resus-
pended in fresh DMEM with 10% FBS. Next, either 100 g/ml or 200 g/ml
gentamicin was added to the supernatant or L929 cells for 5 h, respectively. A
total of 10 l of the supernatant fraction was then diluted in 18 ml BSK-II
medium and plated in a 96-well plate. The infected cells were washed with warm
PBS three times, processed with a sterile pestle to release B. burgdorferi, and then
resuspended in 1 ml of BSK-II medium. A total of 10 l of processed cells was
diluted in 18 ml BSK-II medium and plated in a 96-well plate. Plates were
incubated at 32°C, 1% CO2, and after 2 to 3 weeks a final growth determination
was made.
To test if the attached B. burgdorferi could be killed by gentamicin, cells were
treated with 10 M PP2 to inhibit invasion for 2 h prior to coculture with MSK5
incubated with 5-(and 6-)carboxyfluorescein diacetate succinimidyl ester (CFDA
SE; Invitrogen) according to the manufacturer’s suggestions, to fluorescently
label live B. burgdorferi. After MSK5 infection and treatment with 200 g/ml
gentamicin for 5 h, the cells were treated with Invitrogen’s LIVE/DEAD stain
and scored for viability.
Long-term recovery assay. A total of 1  105 NHDF cells were seeded in
6-well plates overnight and then washed in fresh supplemented DMEM. Subse-
quently, these cells were infected with B. burgdorferi strain MSK5 at an MOI of
10. In some experiments, cultured cells were propagated with 10 M PP2 for 18 h
prior to the addition of B. burgdorferi strain B31 derivative MSK5.
In experiments designed to determine whether B. burgdorferi could be sus-
tained by soluble components released from host cells, NHDF cells were also
seeded in a 0.4-m-pore-size Transwell-COL chamber (Corning Costar Corp.,
Cambridge, MA) and placed in a 6-well plate, and DMEM supplemented with
10% FBS and 2 mM L-glutamine was added to both the upper and lower
compartments. A total of 1  106 MSK5 cells were added to the lower compart-
ment and separated from the NHDF cells by a transwell insert. As a negative
control, B. burgdorferi MSK5 cells alone were also cultured in DMEM in a 6-well
plate. For designated samples, 100 g/ml gentamicin was added for 1 h following
the 18-h coincubation. Fresh DMEM was added every 2 days, with the cells that
initially received PP2 added again to the media at the same concentration. After
4 weeks, 100 l from the samples with B. burgdorferi alone in DMEM, as well as
from the lower compartment of the transwell chamber, was diluted in 18 ml
BSK-II medium and plated in 96-well plates. B. burgdorferi-infected NHDF cells
treated with gentamicin alone, PP2 alone, or gentamicin and PP2 together were
washed with warm PBS three times and processed with a sterile pestle to release
B. burgdorferi. The samples were then resuspended in 1 ml of BSK-II medium. A
100-l aliquot of the processed cell samples was diluted in 18 ml of complete
BSK-II medium and plated in 96-well plates. Plates were incubated at 32°C in 1%
CO2 and, following a 2-week incubation, were scored for growth.
Real-time reverse transcriptase PCR (RT-PCR). To detect borrelial tran-
scripts within infected fibroblasts, 1  106 L929 fibroblasts were grown and
treated as described above and infected with B. burgdorferi MSK5 at an MOI of
1 for 18 h. Following this time frame, the supernatant was removed and placed
in new wells, and the remaining L929 cells were washed three times with PBS and
fed in freshly supplemented DMEM. To half of the samples, 200 g/ml genta-
micin was added to the supernatant and L929 cells for 5 h. The other samples
were not treated with antibiotic. B. burgdorferi cells in the supernatant were
pelleted at 4,000  g for 20 min and washed twice with diethyl pyrocarbonate
(DEPC)-treated PBS. The infected fibroblasts were also washed twice with
DEPC-treated PBS. Both RNA and DNA were extracted using Tri Reagent
(Molecular Research Center, Inc., Cincinnati, OH) according to the manufac-
turer’s instructions. The infection of fibroblasts with MSK5 and the subsequent
isolation of both RNA and DNA were done three separate times independently.
To isolate RNA, samples were treated with a Turbo DNA-free kit (Ambion,
Austin, TX) to eliminate DNA contamination and were subsequently reverse
transcribed into cDNA using the TaqMan reverse transcription reagents kit
(Roche, Branchburg, NJ). For all RNA samples obtained, a PCR without reverse
transcriptase was carried out to test for DNA contamination. The quantification
of live B. burgdorferi spirochetes from both the supernatant and pelleted cells was
assayed using SYBR green PCR master mix (Applied Biosystems Corp., Foster
City, CA) in an Applied Biosystems ABI 7500 fast real-time PCR system.
Both real-time RT-PCR and PCR were conducted, using either cDNA or total
DNA, respectively, in concert with the oligonucleotide primers specific for B.
burgdorferi recA. The primer sequences (5 to 3) were as follows: nTM17FrecA,
GTG GAT CTA TTG TAT TAG ATG AGG CTC TCG; and nTM17RrecA,
GCC AAA GTT CTG CAA CAT TAA CAC CTA AAG. A B. burgdorferi recA
construct, designated pCR2.1/BbrecA (kindly provided by Dana Shaw), was se-
rially diluted starting at 105 copies, subjected to PCR with the recA-specific
primers listed above, and used to construct a standard curve to convert the
threshold cycle (CT) value of the samples tested into the number of borrelial
RNA (cDNA) and DNA copies as previously described (39). A corresponding
standard curve was also generated for -actin as described previously (87).
Statistical analyses. All comparisons of the data presented were performed
using a two-tailed Student t test. For all experiments conducted, the means of
three individual experiments were analyzed and standard deviations were
calculated. Differences were considered statistically significant when the P
values were 0.05.
RESULTS
Nonprofessional phagocytic cells differentially internalize B.
burgdorferi. Previous studies have shown that macrophage cells
degrade phagocytized B. burgdorferi (9, 20, 29, 55, 56, 58, 69,
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70, 81) and that the infection of monocytic cells induces apop-
tosis (20). However, despite these potent killing mechanisms
by innate immune cells, B. burgdorferi is still able to colonize
and maintain an infectious focus even following a potent adap-
tive immune response (80, 81). One possible mechanism em-
ployed by B. burgdorferi to avoid immune clearance might be to
invade nonprofessional phagocytic cells near the site of depo-
sition in the host, such as endothelial cells and/or fibroblasts.
To test this hypothesis, GFP-expressing B. burgdorferi cells
were added at an MOI of 1 to 5 to either L929 fibroblasts,
normal human dermal fibroblast (NHDF) cells, or human
umbilical vein endothelial cells (HUVECs). To evaluate the
internalization of gfp-expressing B. burgdorferi following
the infection of fibroblasts or endothelial cells, we incubated
the infected host cells with a monoclonal antibody specific
for OspA, coupled with an Alexa 594-tagged secondary anti-
body, to distinguish extracellular from intracellular B. burgdor-
feri cells (Fig. 1). Under these experimental conditions, intra-
cellular B. burgdorferi bacteria fluoresce green due to GFP
production, whereas extracellular B. burgdorferi bacteria fluo-
resce both red and green due to their concomitant production
of GFP and their ability to bind antibodies to OspA (Fig. 1).
Using the aforementioned criteria, nearly 4,000 host cells from
each sample were scored in triplicate for both attachment and
invasion as shown in Fig. 1 and documented in Fig. 2.
Each cell type tested exhibited comparable attachment lev-
els of B. burgdorferi (Fig. 2); however, the L929 fibroblasts
exhibited a 5- or 8-fold increase in spirochetal internalization
relative to the NHDF or HUVEC cells, respectively (Fig. 2).
Whereas the normal morphology of the spirochetes was re-
tained for extracellular bacteria, the morphology of some of
the spirochetes changed dramatically when they were internal-
ized (Fig. 1). These anomalous configurations may be due to
the volume constraints of the infected cells or may be reminis-
cent of nutritionally restricted quiescent forms of borrelial cells
that have a cyst-like morphology (4). To confirm the subcellu-
lar localization of the internalized B. burgdorferi, z-series con-
focal microscopy was employed (see Fig. S1 in the supplemen-
tal material). This analysis indicated that B. burgdorferi was
within cells and readily distinguishable from cells that were
attached to the cell surface (i.e., those that were bound by
antibody to OspA). It is important to note that the morphology
of B. burgdorferi within fibroblasts is distinct from that ob-
served in neuronal and neuroglial cells (in which the spiro-
chetes appear more intact [52]), suggesting that different cell
types may provide more hospitable domains for B. burgdorferi
due to alternative processing and/or trafficking within these
different eukaryotic cells. It is also important to note that in all
cases the internalization of B. burgdorferi did not change the
viability of the mammalian cells, based on trypan blue exclu-
sion (data not shown).
Actin reorganization and Src family kinases are involved in
B. burgdorferi invasion. To determine if the invasion of B. burg-
dorferi into L929 fibroblasts involves actin rearrangement, the
effect of cytochalasin D, an inhibitor of actin microfilament
reorganization, was used. When cytochalasin D was added
to the cell culture medium for 2 h prior to the addition of B.
burgdorferi, spirochetal invasion was significantly reduced
(Fig. 3); however, attachment was not adversely affected.
Given that Src kinases are involved in the internalization of
the Gram-positive pathogens Staphylococcus aureus and Strep-
tococcus pyogenes following integrin binding (1, 2, 32, 33, 35,
54, 61, 64), we reasoned that the uptake of B. burgdorferi may
also use a similar mechanism. To test this hypothesis, L929
cells were treated with PP2, a broad-spectrum Src kinase in-
hibitor, for 2 h prior to B. burgdorferi infection. Interestingly,
internalization of B. burgdorferi was completely inhibited in
cells given PP2 relative to those with none added (Fig. 4A).
Another Src family kinase inhibitor, SU6656, which inhibits a
subset of Src kinases (10, 75, 89), significantly inhibited the
internalization of B. burgdorferi but, in contrast to the PP2
treatment, did not abolish it (Fig. 4B). Taken together, these
findings show that both actin reorganization and Src family
kinases are required for the internalization of B. burgdorferi
in vitro.
FIG. 1. Invasion of Borrelia burgdorferi into fibroblast cells. A total
of 1  106 L929 fibroblasts were cultured and infected with B. burg-
dorferi strain ML23/pBSV at an MOI of 5 for 2 h. After the cells were
washed and fixed, the samples were incubated with mouse anti-OspA
antibody and an Alexa 594-tagged secondary antibody. Total GFP
fluorescence (A), detection of only the Alexa 594 signal (B), and merge
of images (C) shown in panels A and B. Arrows in panel C denote
intracellular B. burgdorferi.
FIG. 2. Borrelia burgdorferi invades immortalized and primary fi-
broblasts, as well as primary endothelial cells. Fibroblasts (L929 or
NHDF) or endothelial cells (HUVECs) were infected with ML23/
pEW159 at an MOI of 5 for 18 h. Extracellular B. burgdorferi bacteria
(B.b.) were detected with anti-OspA coupled with an Alexa Fluor 594
secondary antibody. Data shown for extracellular and intracellular B.
burgdorferi are the averages from 3 independent assays from 4,000
host cells analyzed per group per assay (total of 12,000 analyzed).
Error bars depict standard deviation. Asterisks indicate a statistically
significant difference of internalization in NHDF and HUVECs rela-
tive to L929 cells (P  0.001).
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Internalization of B. burgdorferi in eukaryotic cells is not
dependent on BBK32. The invasion of host cells by Staphylo-
coccus aureus requires fibronectin binding via the 51 integrin
(1, 2, 33, 35, 54, 62, 77); therefore, by analogy, we hypothesized
that the borrelial fibronectin binding protein BBK32 (30, 44,
50, 66, 68, 74) was needed for the internalization of B. burg-
dorferi. To test this, strain JS315, an ML23 derivative that
contains a streptomycin resistance cassette inserted into bbk32
(74), was utilized. Accordingly, JS315 does not make BBK32
and exhibits reduced binding to host cells (74). To allow for
easy visualization via epifluorescence, the parent strain ML23
and the bbk32::Strr strain JS315 were transformed with the
gfp-containing plasmid pEW159, and we used an approach
similar to that described above to distinguish between attached
versus internalized B. burgdorferi. ML23/pEW159 and JS315/
pEW159 showed a significant difference in attachment to L929
fibroblasts, consistent with the importance of the BBK32-de-
pendent attachment to cultured eukaryotic cells (74) (Fig. 5A).
There was also a significant decrease in internalization into
fibroblasts of both B. burgdorferi strains; however, the ratios of
extracellular to intracellular B. burgdorferi bacteria of ML23/
pEW159 and JS315/pEW159 were nearly identical, indicating
that the internalization of B. burgdorferi is directly proportional
to its degree of attachment.
To provide evidence that the decreased binding seen for the
FIG. 3. Inhibition of actin polymerization significantly reduces bor-
relial invasion of fibroblasts. Cytochalasin D was added to a final
concentration of 10 nM for 2 h prior to infection of fibroblasts with
ML23/pEW159. The infected cells were processed, and B. burgdorferi
was visualized as indicated in the legend to Fig. 2. Addition of cytocha-
lasin D did not affect fibroblast viability for the duration of the exper-
iment (not shown). The data shown for extracellular and intracellular
B. burgdorferi are the averages from 3 independent assays from 4,000
host cells analyzed per group per assay (total of 12,000 analyzed).
Error bars depict standard deviation. Asterisks indicate a statistically
significant difference in the internalization of B. burgdorferi in fibro-
blasts with or without cytochalasin D (P  0.001).
FIG. 4. Inhibition of Src kinases significantly reduces borrelial in-
vasion of fibroblasts. Fibroblasts were infected with gfp-expressing B.
burgdorferi strain ML23/pEW159 as indicated in the legends to Fig. 2
and 3. The inhibitors PP2 (A) and SU6656 (B) were added to final
concentrations of 10 M and 10 nM for 2 h prior to infection, respec-
tively. The infected cells were processed, and B. burgdorferi was visu-
alized as indicated in the legends to Fig. 2 and Fig. 3. Addition of the
inhibitors did not affect fibroblast viability for the duration of the
experiment (not shown). The extracellular and intracellular B. burg-
dorferi data shown are the averages from 3 independent assays from
4,000 host cells analyzed per group per assay (total of 12,000
analyzed). Error bars depict standard deviation. Asterisks indicate a
statistically significant difference in the internalization of B. burgdorferi
in fibroblasts with and without PP2 (P  0.00001, in panel A) or with
or without SU6656 (P  0.001, in panel B).
FIG. 5. The borrelial Fn binding protein BBK32 does not directly
contribute to invasion of B. burgdorferi. (A) Fibroblasts were infected
with infectious gfp-expressing B. burgdorferi (ML23/pEW159) or a
bbk32::Strr mutant (JS315/pEW159) at an MOI of 5 for 18 h. Borrelial
cells were enumerated as described in the legends to Fig. 2 to 4. The
data shown for extracellular and intracellular B. burgdorferi are the
averages from 3 independent assays from 3,800 host cells analyzed
per group per assay. Error bars depict standard deviation. Asterisks
indicate a statistically significant difference of both attachment and
internalization between ML23/pEW159 and JS315/pEW159 (P 
0.01). (B) Same experiment as described in the legend to panel A
except that gfp-expressing B. burgdorferi (ML23/pEW159) cells were
incubated with antibody to the 51 integrin (10 g/ml) for 1 h prior to
infection. Data shown are the averages from 3 independent assays
from 4,000 host cells analyzed per group per assay (total of 12,000
analyzed). Error bars depict standard deviation. Asterisks indicate a
statistically significant difference of attachment and internalization of
untreated B. burgdorferi relative to cells incubated with 51 antibody
(P  0.01).
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bbk32 mutant was due to its inability to bind the 51 integrin,
we asked how the addition of an antibody specific for the 51
integrin heterodimer affected borrelia-host cell interactions.
The data obtained indicated that the addition of this anti-
body inhibited the attachment of wild-type B. burgdorferi to
levels comparable to that observed for the bbk32 mutant
strain JS315, suggesting that the reduction of binding seen in
JS315 was due, in part, to the loss of binding to 51 integrins
(Fig. 5B). The difference in internalized B. burgdorferi was also
significantly decreased following anti-51 treatment, but in a
manner that was directly proportional to their decreased attach-
ment. Based on these observations, the 51 integrin participates
in the attachment/adherence of B. burgdorferi to fibroblasts but is
not required for invasion of these in vitro-cultivated cells.
Invasion of B. burgdorferi requires 1 integrins. Despite the
observation that the 51 integrin does not seem to be re-
quired for the internalization of B. burgdorferi, it was possible
that other 1 integrins might be involved in this process. To
test this hypothesis, we used a fibroblast cell line that is devoid
of the 1 integrin subunit, designated GD25, and a derivative
line that has been transfected to now synthesize 1 and de-
noted GD251 (27, 32). Subsequent infectivity studies with
these fibroblasts indicated that the 1 subunit is important for
borrelial invasion, given that fibroblasts containing 1 exhibit
3.4-fold-greater internalization and a 2.2-fold-greater attach-
ment-to-invasion ratio relative to fibroblasts lacking the 1
subunit (Fig. 6). These observations suggest that 1 integrins
are involved in the internalization of B. burgdorferi into fibro-
blasts. Furthermore, the absence of a demonstrable change in
borrelial invasion following incubation with antibody against
51 (Fig. 5B) indicates that a 1-containing integrin het-
erodimer other than 51 is involved in the internalization of
B. burgdorferi.
B. burgdorferi remains viable once it is internalized. Since
we hypothesize that the internalization of B. burgdorferi is in-
volved in long-term survival, it follows that internalized B.
burgdorferi would need to retain viability. To test this hypoth-
esis, we applied a variation of the gentamicin protection assay
to B. burgdorferi-infected cells. First, we tested the ability of
gentamicin to kill B. burgdorferi in the culture media used.
Consistent with the known susceptibility of B. burgdorferi to
gentamicin (19, 25), it was not surprising that the exposure of
B. burgdorferi to 100 g/ml or 200 g/ml gentamicin for 5 h in
DMEM completely killed all spirochetes (Fig. 7A). When L929
cells were infected with B. burgdorferi and then exposed to
gentamicin for 5 h, live spirochetes were recovered from pel-
leted cells but never from culture supernatants, suggesting that
the internalization or association of B. burgdorferi cells with the
L929 cells protected them from the bactericidal effect of gen-
tamicin (Fig. 7A).
Previously we found that the addition of PP2 greatly inhib-
ited the internalization of B. burgdorferi but did not alter at-
tachment (Fig. 4A). To independently determine the fate of
borrelial cells exposed to gentamicin, we labeled B. burgdorferi
strain MSK5 with CFSE and then tested how these cells fared
when PP2 was added with or without gentamicin, using the
LIVE/DEAD fluorescent viability stain. The assay indicated
that 97.7% of the extracellular B. burgdorferi cells were killed
following the subsequent 5-h exposure to gentamicin (Fig. 7B),
relative to controls with PP2 alone, of which only 5.1% were
killed (Fig. 7B), suggesting that the live spirochetes observed
following gentamicin treatment alone, shown in Fig. 7A, were
internalized and protected from the bactericidal action of the
added antibiotic.
We next needed an indication that B. burgdorferi cells were
metabolically viable following internalization. To assess this,
we used real-time RT-PCR to quantify borrelial transcripts
following the infection of fibroblasts and treatment with gen-
tamicin. All samples were normalized to total DNA content for
both B. burgdorferi and the infected fibroblasts and conducted
FIG. 6. The integrin 1 subunit is required for borrelial invasion.
Fibroblasts lacking the integrin 1 subunit were exposed to infectious
B. burgdorferi expressing gfp (ML23/pEW159), and attachment and
invasion were assessed as indicated in the legends to Fig. 2 to 5. The
data shown for extracellular and intracellular B. burgdorferi are the
averages from 3 independent assays from 2,000 fibroblasts analyzed
per group per assay (total of 6,000 analyzed). Error bars depict
standard deviation. The asterisk indicates a statistically significant P
value of 0.001 between the levels of invasion observed in cells with or
without the 1 integrin subunit.
FIG. 7. Borrelial invasion is required for survival following antibi-
otic treatment. (A) Viable B. burgdorferi strain MSK5 bacteria are
recovered only from pelleted fibroblasts following exposure to either
100 or 200 g/ml of gentamicin (Gent100 or Gent200, respectively).
Infection of L929 fibroblasts was as described in the legend to Fig. 2.
Growth in medium alone and the culture supernatant with added
gentamicin did not support growth of B. burgdorferi as indicated by the
asterisks. (B) Inhibition by added PP2 and subsequent addition of
gentamicin results in the near elimination of extracellular B. burgdor-
feri strain MSK5. The MSK5 cells represented in panel B were pre-
treated with CFDA SE prior to their addition to the fibroblasts.
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independently in triplicate. The results shown are the ratio of
borrelial recA transcripts to the abundant -actin host cell
transcript, both normalized to their DNA targets. The analysis
indicated that borrelial transcripts detected from pelleted fi-
broblasts were reduced 2.7-fold following incubation with gen-
tamicin, relative to those from parallel samples without added
gentamicin (Fig. 8A). It is important to note that although the
decreased level of recA transcripts per borrelial cell relative to
-actin transcripts per fibroblast implies that the assay was
insensitive for B. burgdorferi transcripts, the CT values for all
RNA targets averaged 17.7 and 17.2 for both recA and -actin,
respectively (data not shown), indicating the high-level expres-
sion of both targeted genes. Controls with no added reverse
transcriptase had nearly undetectable CT values (data not
shown), indicating that the signals detected were due to cDNA
converted from RNA in all samples tested. As shown in Fig.
7B, nearly all of the spirochetes were killed by gentamicin
treatment if invasion was abrogated by added PP2. As such,
these results strongly suggest that the majority of the tran-
scripts detected are from borrelial cells that reside intracellu-
larly. In support of this contention, supernatants from the
infected fibroblast cultures treated with gentamicin exhibited a
66.7-fold reduction in borrelial transcripts relative to samples
lacking any added antibiotic (Fig. 8B). This is in stark contrast
to the pelleted cells, for which a 2.3-fold decrease in borrelial
transcript was observed following exposure to gentamicin (Fig.
8B), presumably due to the killing of borrelial cells that are
attached but not internalized. The vast difference in borrelial
transcript levels, based on extracellular versus intracellular lo-
cales (e.g., not as reduced following antibiotic treatment in
pelleted cells relative to culture supernatants) support the no-
tion that B. burgdorferi cells are metabolically active following
internalization into cultured fibroblasts.
B. burgdorferi cells survive following long-term coculture
with primary fibroblasts. Although the initial short-term in-
fection of the L929 cells provided support to our hypothesis
that B. burgdorferi can survive intracellularly in nonimmune
cells, we were interested in determining if primary cells exhib-
ited this same protection following infection. To assess this, we
used NHDFs (primary cells) infected with B. burgdorferi strain
MSK5. NHDFs are suited for this type of study since they can
be cultivated for several weeks following infection and various
treatments. Following infection, NHDFs afforded similar pro-
tection to B. burgdorferi following subsequent treatment with
gentamicin following a 4-week coinfection (Fig. 9). If invasion
was inhibited by the addition of PP2, spirochete levels were
4-fold less than those in cells treated with gentamicin alone
(Fig. 9), implying that some B. burgdorferi cells may be able to
survive long term or within the secreted extracellular matrix
produced by the primary fibroblasts or may escape from in-
fected NHDFs over time. Alternatively, the concentration of
PP2 used may not have inhibited invasion for the duration of
the experiment, and we do not know whether the cells detected
FIG. 8. Intracellular B. burgdorferi cells are metabolically active.
(A) Transcripts of borrelial recA were detected following infection with
B. burgdorferi MSK5 of pelleted L929 fibroblasts (18-h infection at an
MOI of 1), in the absence and presence gentamicin (at 200 g/ml for
5 h postinfection) as indicated and normalized to their respective DNA
targets. The values shown are the ratio of borrelial recA transcripts per
borrelial genome equivalents relative to -actin transcripts per -actin
genomic copies (divided by two). Error bars represent standard devi-
ation. (B) Added gentamicin dramatically reduces the amount of tran-
scripts from extracellular B. burgdorferi. Pelleted fibroblasts (black
bars) and the resulting supernatant (gray bars) were tested for their
levels of recA transcripts relative to recA genomic copies following
standard cultivation (no treatment) and incubation with gentamicin.
The values shown indicate the ratio of the recA transcripts to recA
genomic equivalents within the samples tested. Error bars indicate
standard deviation.
FIG. 9. B. burgdorferi survives following long-term coculture with
primary dermal fibroblasts (NHDFs) following gentamicin exposure.
NHDFs were infected with B. burgdorferi at an MOI of 10 for 18 h and
either left untreated, incubated with gentamicin for 1 h, exposed to
PP2 for 1 h, or treated with both gentamicin and PP2 for 1 h as
indicated above. Subsequently the samples were propagated for 28
days in DMEM, pelleted, washed, processed to release B. burgdorferi,
and then scored for growth as described in Materials and Methods.
The overall growth (per well) from 3 independent assays was compiled
and converted to the percentage of total wells tested, and the un-
treated sample was normalized to a value of 1.0. The errors listed and
the error bars shown represent the standard deviations of the three
independent assays conducted. Based on their observed growth, the
other samples were adjusted and compared accordingly.
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in this assay are extracellular or intracellular. Nevertheless, the
enhanced recovery of B. burgdorferi in primary fibroblasts that
were treated with gentamicin relative to PP2 alone suggested
that the majority of recovered B. burgdorferi cells were the
result of invasion and subsequent protection from the bacteri-
cidal action of the antibiotic (Fig. 9). The concurrent addition
of gentamicin and PP2 completely abrogated the recovery of B.
burgdorferi (Fig. 9). As controls, spirochetes that were cultured
in either tissue culture medium alone (DMEM, 10% FBS)
without NHDFs or in a transwell plate sharing the cell culture
supernatant with NHDF host cells, and thus unable to contact
the NHDF cells, were not viable (data not shown). These
results indicated that neither the tissue culture media nor sol-
uble factors released from cultured primary fibroblasts could
support the growth of B. burgdorferi, providing further support
that the majority of the long-term borrelial survivors observed
were due to the internalization of the spirochete within the
NHDF cells.
DISCUSSION
In order to establish a persistent infection, pathogens must
evade absolute clearance from the host innate and adaptive
immune responses and/or the bactericidal or bacteriostatic ef-
fect of administered antibiotics. During late-stage B. burgdor-
feri infection, high-titered antibodies that efficiently kill B.
burgdorferi in vitro are ineffective at clearance (3, 5, 28, 80, 81).
This is due presumably to the ability of B. burgdorferi to occupy
unknown immunoprivileged niches during experimental infec-
tion where it may avoid innate and adaptive immune-mediated
killing. To circumvent host clearance, some pathogens invade
immune cells and alter the ability of these cells to kill them by
quelling their antimicrobial activity and/or modifying normal
host cell trafficking (reviewed recently in references 23 and 31).
However, in vitro-cultivated B. burgdorferi cells are not known
to override the killing mediated by innate immune cells and, as
a consequence, for the most part are cleared by these cells in
vitro (9, 20, 29, 56–58, 69, 81).
Historically B. burgdorferi has been categorized as an extra-
cellular pathogen, but this is due primarily to the inability to
detect B. burgdorferi in appreciable numbers during the infec-
tious process. Although the ability of B. burgdorferi to survive
within connective tissue has been observed (6, 36, 38), it is also
possible that these spirochetes may invade and replicate at low
levels inside nonimmune cells, such as fibroblasts, endothelial
cells, and neuronal and neuroglial cells (24, 46, 52, 53). Along
these lines, previous studies demonstrated that B. burgdorferi
invades human umbilical vein endothelial cells (HUVECs),
human-foreskin fibroblasts, and an immortalized B cell line
(24, 46, 53). The major limitation of these studies was the high
multiplicity of infection (MOI) employed, ranging from 100 to
5,000, since this bacterial load is unlikely to be physiologically
relevant, and the lack of information provided regarding the
fate of the borrelial cells. More recently Livengood and Gil-
more demonstrated that B. burgdorferi is taken up by both
neuronal and neuroglial cells at a lower MOI and appear to be
unaffected, at least morphologically, following this process
(52). In our studies, we infected immortalized L929 fibroblasts,
as well as primary normal human dermal fibroblasts (NHDFs)
and HUVECs, with gfp-expressing B. burgdorferi at an MOI of
1 to 5, which is significantly lower and, by our estimation, more
in agreement with what might occur initially in the infectious
process. While the extracellular B. burgdorferi spirochetes kept
their linear coiled shape, over time the intracellular spirochetes
changed their morphology (Fig. 1). Because of the length of
linear B. burgdorferi, we speculate that this anomalous config-
uration may be either due to volume constraints of the host
cells or reminiscent of nutritionally restricted quiescent cells
having a cyst-like morphology (4). Although unproven, it is
tempting to speculate that some of the intracellular forms
observed may represent the cyst morphology and can be re-
covered when they are provided with a nutritionally replete
environment.
The enhanced internalization in L929 cells relative to human
primary fibroblasts (Fig. 2) suggests that murine cells are either
more adept at internalizing B. burgdorferi or less capable of
eliminating the spirochetes relative to primary human cells due
to the different densities of host receptors for B. burgdorferi or
significant differences in intracellular trafficking of internalized
spirochetes. These differences also imply that internalization of
B. burgdorferi is a rare event in vivo and may explain why such
localized niches are not well characterized. Further insight into
the trafficking mechanisms of internalized B. burgdorferi may
delineate the differences observed between the murine L929
and human primary dermal fibroblast cells.
Given that integrin binding of pathogenic bacteria, in con-
cert with fibronectin binding, is known to mediate adherence
and invasion of eukaryotic cells and contribute to their ability
to infect susceptible hosts (reviewed recently in references 12,
34, and 43), we asked whether a similar activity could be at-
tributable to B. burgdorferi. Previously we determined that
BBK32 was required for maximal binding to fibroblasts (74),
and while the studies herein confirmed this prior observation,
the degree of invasion was commensurate with binding (Fig.
5A). The results indicate that, although BBK32 was not re-
quired for invasion (Fig. 5A), some 1 integrin structure was
needed (Fig. 6). The alternative  subunit that engages the 1
subunit for borrelial invasion is not known but, based on
known expression profiles of fibroblasts, may be the 1, 2, 3,
8, or 11 subunit (11, 15, 42, 48, 83, 85). Recently 31-B.
burgdorferi interactions were reported for chondrocytes (7, 8),
and given the abundance of 31 in a number of cell types (21,
45, 49, 82), as well as the ability of 31 to bind a large number
of extracellular matrix proteins, including fibronectin, laminin,
and collagen (22, 26, 88), it is possible that 31 may mediate
the B. burgdorferi-host cell interaction observed.
One possibility for the difference in invasive activity associ-
ated with B. burgdorferi fibronectin binding could be due to the
different stoichiometry of BBK32 and fibronectin binding rel-
ative to that of other fibronectin binding proteins from Gram-
positive pathogens, even though Borrelia and the Gram-posi-
tive pathogens all use the tandem -zipper mechanism for
binding host fibronectin (17, 37, 44, 65, 68, 71, 72). Specifically,
SfbI and the FnBPs from Streptococcus and Staphylococcus, re-
spectively, each contain multiple amino terminal domain (NTD)
binding sites that recognize F1 modules on fibronectin and
promote integrin clustering and the subsequent invasion of
these pathogens (17, 37, 44, 65, 68, 71, 72). In contrast, BBK32
contains a sole NTD binding site and, as such, may not be able
to attract enough integrins to cluster in order to trigger the
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downstream signaling pathway needed for optimized internal-
ization. Despite these limitations, it is clear that B. burgdorferi
is capable of invasion in vitro.
The observation that exposure to cytochalasin D, a potent
inhibitor of actin polymerization, inhibited the internalization
of B. burgdorferi indicated that actin microfilament reorgani-
zation is also required for borrelial invasion (Fig. 3). Actin
reorganization is triggered by integrin signaling pathways and
plays an important role in the invasion of several intracellular
pathogens (reviewed recently in references 12, 18, 35, and 43).
Furthermore, integrin signaling pathways are activated by in-
teractions with extracellular matrix components, including fi-
bronectin (1, 2, 32, 33, 35, 54, 62, 77), resulting in the afore-
mentioned integrin clustering and characteristic activation of
kinases, including the Src family protein tyrosine kinases
(PTKs), focal adhesion kinase (FAK), and several actin-bind-
ing adaptor molecules (1, 2, 32, 63). As such, B. burgdorferi
utilizes common mechanisms exploited by other pathogens to
invade eukaryotic cells. As indicated above, how borrelial cells
ultimately traffic once inside host cells and how this factors into
long-term survival are not known.
Given that several intracellular pathogens utilize Src kinase
for internalization and dissemination (16, 32, 51, 61, 78, 90), we
tested whether specific Src family kinase (SFK) inhibitors in-
hibited B. burgdorferi internalization in vitro. Specifically, Src
kinase activity is required for the internalization of Neisseria
spp. and Staphylococcus aureus and is needed for both Strep-
tococcus pneumoniae and Bacillus anthracis dissemination
(albeit via different mechanisms), given that translocation
through lung epithelial cells is inhibited when SFK inhibitors
are added in vitro to experiments with the last two pathogens
(1, 2, 32, 63, 78, 89). In a comparable manner, the addition of
PP2 clearly inhibits B. burgdorferi invasion (Fig. 4A); however,
it is still not known which of the SFK members are involved in
this process. Since SU6656 has been shown to alter the dis-
semination of B. anthracis during infection (89), it is possible
that B. burgdorferi dissemination and/or long-term survival may
be adversely affected in existing SFK knockout mice or in mice
that are treated over time with SU6656. Additional experimen-
tation is required to address this possibility.
Our intent with the modified gentamicin recovery experi-
ment was to determine whether B. burgdorferi could be pro-
tected from the bactericidal effect of the antibiotic, thereby
providing evidence that the spirochetes resided intracellularly.
Typically, colony formation is used as a readout for survival but
requires detergent treatment or osmotic lysis to release intra-
cellular bacteria; however, the fragile nature of B. burgdorferi
made these techniques untenable (i.e., no viable spirochetes
were recovered). To circumvent this dilemma, we lysed cells
mechanically and found that B. burgdorferi spirochetes were
recovered from host cell pellets, but not from the cell culture
supernatant, following 5 h of treatment with gentamicin, sug-
gesting that the recovery of live B. burgdorferi spirochetes was
due to their intracellular locale (Fig. 7A). This result is con-
sistent with the observation that antibiotics with increased in-
tracellular penetration, i.e., doxycycline and erythromycin, are
more efficient at clearing B. burgdorferi when cocultured with
eukaryotic cells (13) and given to treat infection (3, 80, 81).
Furthermore, our quantitative RT-PCR results that quantify
recA transcripts strongly support the contention that B. burg-
dorferi cells are internalized and are metabolically active fol-
lowing gentamicin exposure under conditions that clear nearly
all spirochetes (Fig. 7 and 8). Whether the internalized borre-
lial cells are capable of replication is not clear, but our obser-
vations, as well as those by Livengood and Gilmore, of B.
burgdorferi inside neuroglial cells (52), suggest that the spiro-
chetes do not attain high numbers but instead appear to be in
a quiescent but viable state. Despite these limitations, viable
spirochetes are recovered from both neural cells and fibro-
blasts and may reflect differential processing and or trafficking
mechanisms that factor into the ability of B. burgdorferi to
survive in distinct niches within the infected host.
Finally, we asked whether the intracellular survival of B.
burgdorferi observed was limited to the short time frame of our
and others’ analyses. The results indicated that, while no live
spirochetes were recovered in the cell culture supernatant,
viable B. burgdorferi cells were obtained at a higher rate and
preferentially from primary fibroblasts that were treated with
gentamicin alone, suggesting that the ability to invade cells
prior to the addition of antibiotic protected them and provided
the best chance for survival. It is true that a small proportion of
cells survived the treatment with the potent SFK inhibitor PP2
alone (Fig. 9), but even if these cells were capable of residing
extracellularly, they are still at a significant disadvantage rela-
tive to cells that are internalized, based on the data shown in
Fig. 7A and B. One limitation of these studies is the inability to
track whether B. burgdorferi can be released from infected cells
and repopulate the extracellular milieu of the cultured primary
fibroblasts. Given the sensitivity of B. burgdorferi within the cell
culture medium (Fig. 7A), it seems unlikely that the spiro-
chetes would be viable in this environment. The studies de-
scribed herein provide the foundation to further evaluate the
importance of the intracellular localization and trafficking of B.
burgdorferi following long-term infection.
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